According to the research report titled ‘Global Coronavirus Diagnostics Market Size study, by Type of Test (Molecular and Serology), by End-User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs and Others) and Regional Forecasts 2020-2026’, available with Market Study Report, global coronavirus diagnostics market is expected to grow substantially during 2020-2026.
 

For those unaware, COVID-19 i.e., the novel corona virus disease is caused by SARS-COV-2 and is generally transmitted from humans to humans, and animals to humans. The virus spreads through the infected person’s nose discharge when they sneeze or cough or from their blood droplets.
 

The spread of the disease through the person’s nose discharge was first recognized in Wuhan, China, in late December 2019, after which the outbreak has been observed in several infected areas across the globe. In fact, as of 9 April 2020, around 1.5 million cases were recorded worldwide, with over 330,000 recovered and mortality numbers up to 88,000
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2633103/
 

As per the U.S. Centers for Disease Control and Prevention, a considerable number of patients infected by this disease had fever and acute respiratory symptoms. The findings were taken from laboratory or clinical experiments done on patients in initial phase of the infection. A drop in number of lymphocytes in white blood cells have been observed from the specimens obtained from patient’s blood.
 

However, blood samples of critical patients showed an increase in D-dimer and a substantial decline in number of lymphocytes in white blood cells. The diagnosis of COVID-19 is based on predictions, oxygen therapy is a suggested during medical procedures of diagnosed individuals with acute corona virus infection.
 

During oxygen therapy, automatic ventilation systems are used to avoid respiratory collapse, and assistance of hemodynamic is needed to handle septic shock skillfully. According to WHO, as of 28 January 2020, respiratory failures may be treated by giving high flow of nasal oxygen or safe automatic ventilation & non-invasive ventilation. Furthermore, consumption and inoculation of ritonavir alpha-interferon / Lopinavir, or drug has been approved by UN’s public health body.
 

Citing the regional landscape, North America holds a significant market share and is expected to grow substantially over the analysis period, owing to favorable health insurance policies and availability of a developed medical infrastructure. High concentration of major companies is also favoring the market outlook in North America.
 

Major contenders in global coronavirus diagnostics market are Abbott Laboratories, GlaxoSmithKline Biologicals SA, QIAGEN, Hologic, Inc., BioMérieux SA, Lonza Group, Becton, Dickinson and Company, Beckman Coulter Inc., Bio-Rad Laboratories Inc., and F. Hoffmann-La Roche AG.